Latest Avita Medical Ltd (AVMXF) Headlines



Avita Medical Announces Completion of Enrollment in ReCell(R) Trial for Vitiligo

Marketwire - Wed Aug 21, 7:01AM CDT

Avita Medical Ltd. (ASX: AVH) (PINKSHEETS: AVMXF) (OTCQX: AVMXY)



Avita Medical Enrolls First Patients in ReCell(R) Trial for Chronic Leg Ulcers

Marketwire - Thu Aug 01, 8:30AM CDT

Avita Medical Ltd. (ASX: AVH) (PINKSHEETS: AVMXF) (OTCQX: AVMXY)



Granted Japanese Patent Expands Commercial Rights for ReCell(R) Spray-On Skin(R) Technology in Asia

Marketwire - Wed Apr 10, 8:30AM CDT

Regenerative medicine Company Avita Medical Ltd. (ASX: AVH) (PINKSHEETS: AVMXF) (OTCQX: AVMXY) is pleased to announce that it has secured the grant of Japanese Patent No. 5214085 "Cell Suspension Preparation Technique and Device" by the Japanese Patent Office.